NCT02412644View on ClinicalTrials.gov

Apremilast 30mg Bid With Narrowband UVB in the Treatment of Plaque Psoriasis

PHASE4CompletedINTERVENTIONAL

Enrollment

29

Participants

Timeline

Start Date

May 28, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions

Plaque Psoriasis

Interventions

DRUG

apremilast

Trial Locations (1)

08520

Psoriasis Treatment Center of Central New Jersey, East Windsor

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Celgene

INDUSTRY

lead

Psoriasis Treatment Center of Central New Jersey

OTHER